See a Demo

Category: News

TrialAssure cubes divider
TrialAssure Wins “Data Privacy Solution of the Year” for AI-Powered Anonymization and Redaction Platform CANTON, Mich. (April 16, 2026) – TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced today that its TrialAssure ANONYMIZE product has been named Data Privacy Solution of the Year in the 2026 Data Breakthrough Awards program. TrialAssure ANONYMIZE supports data sharing and transparency initiatives by automatically identifying sensitive information, applying consistent anonymization rules, and providing full auditability for the pharmaceutical and biotechnology industry. | TrialAssure Wins Prestigious MichBusiness Triple Trusted Advisors Award for its Innovative AI Solutions

TrialAssure Wins “Data Privacy Solution of the Year” for AI-Powered Anonymization and Redaction Platform 

by Staff Writer | April 2026

Posted in Blog, News
Read More
AI for Medical Writing Certification (AIMWC) Program

AI in Medical Writing Certification Program Launched by TrialAssure to Support Greater Adoption Across Pharma and Biotech

by Staff Writer | March 2026

Posted in Blog, News
Read More
Austin TX

TrialAssure to Lead Discussions on CCI and Smart Anonymization at PHUSE US Connect 2026 in Austin

by Staff Writer | February 2026

Posted in Blog, News
Read More
TrialAssure Establishes Physical Presence in The Netherlands

TrialAssure Establishes Physical Presence in The Netherlands to Advance Clinical Trial Transparency and Data Sharing Across Europe

by Staff Writer | January 2026

Posted in Blog, News
Read More
TrialAssure Officially Granted New Patent for Date Offset Anonymization Technology by U.S. Patent and Trademark Office

TrialAssure Officially Granted New Patent for Date Offset Anonymization Technology by U.S. Patent and Trademark Office

by Staff Writer | December 2025

Posted in Blog, News
Read More
Chris Hurley

Respected Data Science Industry Leader Chris Hurley Joins TrialAssure Advisory Leadership Team to Strengthen Data Strategy and Innovation

by Staff Writer | December 2025

Posted in Blog, News
Read More
TrialAssure Introduces Enhanced Architectural Techniques to Improve Accuracy, Visibility, Traceability, and Control Across its AI Platform for Pharma and Biotech Innovative application architecture gives users clearer insight into AI responses, improves output reliability, and strengthens data alignment across LINK AI®, ANONYMIZE®, and REGISTRY® CANTON, Mich. (October 7, 2025) – TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced the launch of its new enhanced content search and sourcing capability, a technical upgrade designed to boost accuracy, transparency, and reliability across its suite of AI-powered tools. This advancement enables a more structured way for artificial intelligence (AI) to interpret, segment, and retrieve information from source documents, enabling users to gain more precise insights and greater control over the content. TrialAssure has introduced an integrated framework that leverages AI Large Language Models (LLMs) to process and manage content more effectively. This framework emphasizes efficient document ingestion and chunking, optimized embedding and indexing, structured information storage, and advanced AI prompt design and engineering. These techniques replace the out-of-the-box indexing and retrieval approaches and improve the visibility and traceability of AI responses, giving users greater confidence and a more efficient approach to generating structured and regulated documents in the life sciences arena. This also creates a more flexible and tailored experience, allowing AI models to separate, label, and group source material with greater specificity. For instance, information used to create clinical narratives can now be isolated by individual trial participants to eliminate cross-contamination and improve document fidelity. “Giving the pharma and biotech industry clarity into how AI reaches its outputs was a technical challenge at first, but it is our usability promise,” said Zach Weingarden, MS, Director of AI Technology & Applications, TrialAssure. “We are focused on raising the standard for how AI can operate transparently in highly regulated environments like life sciences.”

TrialAssure Introduces Enhanced Architectural Techniques to Improve Accuracy, Visibility, Traceability, and Control Across its AI Platform for Pharma and Biotech

by Staff Writer | October 2025

Posted in Blog, News
Read More
TrialAssure & Certara Joint Webinar: Authoring Clinical Documents with Downstream Regulatory Requirements in Mind

New Webinar Announced on Stronger Clinical Document Authoring Workflows with Certara & TrialAssure

by Don McLean | September 2025

Posted in Blog, News
Read More
AI in Drug Development

TrialAssure’s Zach Weingarden Joins Other Pharmaceutical Industry Leaders to Present on the Future of AI in Drug Development at RAPS Convergence 2025

by Don McLean | August 2025

Posted in Events, News
Read More
AI for clinical trial registration using TrialAssure REGISTRY

TrialAssure Enhances REGISTRY Platform with AI-Powered Protocol Parsing to Streamline Global Clinical Trial Registration

by Don McLean | June 2025

Posted in Blog, News
Read More
Get in Touch

Looking to streamline your clinical trial disclosure and transparency efforts?

TrialAssure is ready to help your organization embark on a Transparency Transformation!

To learn more about the TrialAssure Transparency Suite, specific products, or our company, contact us below.

Yes, please send me more information about TrialAssure.